Sense Biodetection
UKWho owns Sense Biodetection?
Sense Biodetection is a British MedTech company, now owned by Sherlock Biosciences, which acquired it in 2023 from Mercia Asset Management and Cambridge Innovation Capital.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2023 to Sherlock Biosciences.
- ·Average hold across 2 realized cycles: 6 years.
Ownership history
2 ownership periods · co-invest detected
Mercia Asset Management sold Sense Biodetection to Sherlock Biosciences in 2023 after 7 years.
Cambridge Innovation Capital sold Sense Biodetection to Sherlock Biosciences in 2023 after 4 years.
More from Mercia Direct Investments
Other portfolio companies in the same fund.
SwedenMore PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns Sense Biodetection?
Sense Biodetection is now owned by Sherlock Biosciences, which acquired it in 2023 from Mercia Asset Management and Cambridge Innovation Capital.
When did Sherlock Biosciences acquire Sense Biodetection?
Sherlock Biosciences acquired Sense Biodetection in 2023, buying from Mercia Asset Management and Cambridge Innovation Capital.
Who did Sense Biodetection sell to?
Mercia Asset Management and Cambridge Innovation Capital sold Sense Biodetection to Sherlock Biosciences in 2023 (Trade Sale).
Who has owned Sense Biodetection over time?
Sense Biodetection has been through 2 private-equity ownership periods: Mercia Asset Management · via Mercia Direct Investments · 2016–2023 · sold to Sherlock Biosciences · (Trade Sale); Cambridge Innovation Capital · via CIC Fund I · 2019–2023 · sold to Sherlock Biosciences · (Trade Sale).